Aurobindo Pharma Limited — Others, 22-11-2024: Copy of Newspaper Publication

Aurobindo Pharma has announced a board meeting to discuss and approve the financial results for the quarter and half-year. Additionally, the company is set to transfer equity shares to the Investor Education and Protection Fund (IEPF) due to unpaid dividends remaining unclaimed for seven consecutive years. Shareholders have been informed to take action by submitting claims before March 5, 2025. This move may affect shareholder sentiment as it emphasizes the company's commitment to compliance, but it also highlights the potential loss of unclaimed equity for some investors, introducing a possible negative impact.